Molecular diagnosis of HIV

Expert Review of Molecular Diagnostics

Volumn 2, Issue 3, 2002, Pages 233-239

  Clarke, John R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Genotypic resistance assays; HIV vial load; Molecular diagnosis of HIV; Real time PCR

Indexed keywords

GLYCOPROTEIN GP 41;

GENE AMPLIFICATION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR BIOLOGY; PATIENT CARE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; VIRUS LOAD;

EID: 0036086771     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.2.3.233     Document Type: Review

References (41)

1. HIV-1 viral load and clinical outcome: Review of recent studies
2. Viral dynamics in human immunodeficiency virus Type 1 infection
3. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
4. Decay characteristics of HIV-1 infected compartments during combination therapy
5. HIV infection is active and progressive in lymphoid tissue during the clinical latent stage of disease
6. Massive covert infection of helper T-lymphocytes and macrophages by HIV during the incubation period of AIDS
7. Quantitative image analysis of HIV-1 infection in lymphoid tissue
8. Prognosis of HIV-1 infection predicted by quantity of virus in plasma
9. Time to hit HIV early and hard
10. Application of branched DNA signal amplification to monitor human immunodeficiency virus Type 1 burden in human plasma
11. Quantification of viral nucleic acids using branched DNA signal amplification
12. Multicenter comparison of the three commercial methods for quantification of human immunodeficiency virus Type 1 RNA in plasma
13. Performance characteristics for quantification of plasma HIV-1 RNA using brached DNA signal amplification technology
14. Diurnal and short-term stability of HIV virus load as measured by gene amplification
15. Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in Vacutainer CPT, Vacutainer PPT, and standard Vacutainer tubes
16. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus Type 1 RNA in plasma by the AIDS clinical trials group virology laboratories
17. Quantification of HIV-1 RNA in plasma: Comparable results with NASBA HIV-1 RNA QT and the Amplicor monitor test
18. Longitudinal study of HIV-1 RNA concentrations during the asymptomatic stage of HIV-1 infection measured using Amplicor HIV monitor and NASBA HIV-1 RNA QT
19. Rapid and simple PCR assay for quantitation of human immunodeficiency virus Type 1 RNA in plasma: Application to acute retroviral infection
20. Variance of plasma human immunodeficiency virus type-1 RNA levels measured by branched DNA within and between days
21. Comparative evaluation of NASBA HIV-1 RNA QT, Amplicor HIV Monitor and Quantiplex HIV RNA assay: Three methods for quantification of human immunodeficiency virus Type 1 RNA in plasma
22. Comparative performance of three viral load assays on human immunodeficiency virus Type 1 isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, Amplicor HIV-1 monitor version 1.5 and Quantiplex HIV-1 RNA version 3.0
23. Comparative quantification of diverse serotypes of HIV-1 in plasma from a diverse population of patients
24. Problems in the interpretation of HIV-1 viral load assays using commercial reagents
25. HIV viral load testing
26. Use of real time PCR and molecular beacons to detect virus replication in human immunodeficiency virus Type 1 infected individuals on prolonged effective antiretroviral therapy
27. Taqman 5′ nuclease human immunodeficiency virus Type 1 PCR assay with phage packaged competitive internal control for high-throughput blood donor screening
28. Continuous fluorescence monitoring of rapid cycle DNA amplification
29. The lightcycler: A microvolume multisample fluorimeter with rapid temperature control
30. A new method of using molecular genetics for medical diagnosis
31. Zidovudine resistance predicted by direct detection of mutations in DNA from HIV infected lymphocytes
32. A microtitre format point mutation assay: Application to the detection of drug resistance in human immunodeficiency virus Type 1 infected patients treated with zidovudine
33. Line probe assay for rapid detection of drug selected mutations in the human immunodeficiency virus Type 1 reverse transcriptase gene
34. Comparison of a point mutation assay with a line probe assay for the detection of the major mutations in the HIV-1 reverse transcriptase gene associated with reduced susceptibility to nucleoside analogues
35. Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy
36. Comparison of line probe assay (LiPA) and sequence analysis for detection of HIV-1 drug resistance
37. Antiretroviral drug resistance testing in adults with HIV infection; implications for clinical management
38. Detection of newly emerging primary genotypic mutations at less than 50 copies/ml with maintained presence at breakthrough in longitudinal plasma samples from patients on triple combination therapy
39. HIV-1 genetic subtypes and antiretroviral therapy resistance testing
40. Human immunodeficiency virus Type 1 drug resistance testing: A comparison of three sequence based methods
41. Performance of Applied Biosystems Viroseq HIV-1 genotyping system for sequence based analysis of non-subtype B human immunodeficiency virus Type 1 from Uganda